Answers are grounded in this paper and cite their sources.
Large language models (LLMs) show considerable promise for clinical decision support (CDS) but none is currently authorized by the Food and Drug Administration (FDA) as a CDS device. We evaluated whether two popular LLMs could be induced to provide unauthorized, device-like CDS, in violation of FDA's requirements. We found that LLM output readily produced device-like decision support across a range of scenarios despite instructions to remain compliant with FDA guidelines.
No takes yet. Share an insight, caveat, or question.
Weissman et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: